Cargando…
Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy
Successful cancer immunotherapy is confounded by the magnitude of the tumor burden and the presence of immunoregulatory elements that suppress an immune response. To approach these issues, 26 patients with advanced treatment refractory cancer were enrolled in a safety/feasibility study wherein a con...
Autores principales: | Hasumi, Kenichiro, Aoki, Yukimasa, Watanabe, Ryuko, Hankey, Kim G., Mann, Dean L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757414/ https://www.ncbi.nlm.nih.gov/pubmed/24212806 http://dx.doi.org/10.3390/cancers3022223 |
Ejemplares similares
-
Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy
por: Hasumi, Kenichiro, et al.
Publicado: (2013) -
Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
por: Voskens, Caroline J, et al.
Publicado: (2010) -
Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection?
por: van der Sluis, Renée M., et al.
Publicado: (2020) -
Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020) -
Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)